166 filings
Page 3 of 9
6-K
sp7 r2dqs7svmo
4 May 23
Second Amendment to Loan and Security Agreement
4:18pm
NT 20-F
8fhfqgkwq5 77
28 Apr 23
Notice of late annual filing (foreign)
7:27am
6-K
a80gtw8qa5t6
28 Apr 23
CENTOGENE Receives Nasdaq Non-Compliance Notice
7:25am
6-K
xskwzz
26 Apr 23
CENTOGENE Accelerates Global Genetic Data Interpretation, Launching FilterTool Application as Accessory to CentoCloud® Bioinformatics Pipeline
8:16am
6-K
xvqgqkkjd9zdg41mbpf
12 Apr 23
CENTOGENE Launches NEW CentoGenome®, World’s Most Comprehensive Whole Genome Sequencing Solution for Diagnosis of Rare and Neurodegenerative Diseases
6:30am
6-K
fdj4b2626k y2xf
11 Apr 23
CENTOGENE Extends Strategic Partnership With Takeda to Continue Providing Access to Genetic Testing for Patients With Lysosomal Storage Disorders
6:30am
6-K
yoge9ej
28 Mar 23
Current report (foreign)
6:30am
6-K
o7aov11
14 Mar 23
Current report (foreign)
8:41am
6-K
7bk6jq nh07pq
9 Mar 23
CENTOGENE Appoints Ian Rentsch as Chief Commercial Officer and General Manager - Pharma
6:30am
6-K
fbylz7g 43fux
21 Feb 23
Current report (foreign)
6:31am
6-K
ap8w54uxcb2p 9adbai
7 Feb 23
Current report (foreign)
8:00am
6-K
khwsd 05w5
30 Jan 23
CENTOGENE Announces Executive Appointment
4:30pm
6-K
0ybs2o1dfcwj3hm6o8
19 Jan 23
CENTOGENE Announces Departure From Executive Team
8:01am
6-K
agemqeh4mnf ognamua
10 Jan 23
Twist Bioscience and CENTOGENE Launch Three Panels to Advance Rare Disease and Hereditary Cancer Research and Support Diagnostics
8:00am
6-K
bgwjg5h
9 Jan 23
Current report (foreign)
8:30am
6-K
9ab20wd uu
9 Jan 23
Premier Research and CENTOGENE Launch Strategic Partnership to Accelerate and De-Risk Rare Disease Clinical Development
8:03am
6-K
6bg4hn6m t1
22 Dec 22
CENTOGENE Reports Second Quarter and First Half 2022 Financial Results
4:13pm
6-K
nvqo04 ko5fzce5
16 Dec 22
CENTOGENE Receives Nasdaq Non-Compliance Notice
4:33pm
6-K
8umd2u 2lg9wb9cg
21 Nov 22
CENTOGENE Announces Changes to Supervisory Board, Including Appointment of Mary Sheahan
6:30am
6-K
yh1caqdv lnagn26s1
3 Nov 22
Current report (foreign)
6:05am